[ad_1]
The Emirates Cardiology Society has announced that it will host the GCC’s first-of-its-kind conference ‘Women’s Cardiovascular Disease Conference’ on 3-4 February in Dubai.
The meeting was initiated in cooperation with the Saudi Heart Association (Saudi Heart Association), and the expert group and specialist physicians jointly discussed the latest progress and research related to female heart disease.
With the participation of experts from the GCC (UAE, Saudi Arabia, Bahrain and Oman) and Dr. Alaide Cheffo from Italy, the event will be held in conjunction with the International Women’s Heart Disease Awareness Day, which will be held globally on 3 February 2023.
promotional activity
During the Women’s Heart Congress, the society will organize awareness events throughout the year to present and raise awareness about heart disease in the form of multiple virtual workshops, as well as several initiatives in UAE business centers and malls, where blood pressure is measured , body mass index, sugar and cholesterol, as well as health tips and guidance on fitness and nutrition for women.
The Women in CVD conference committee will include Dr Juwairia Alali, President of the Emirates Society of Cardiology, Dr Abdullah Shehab, Vice-President, and Dr Wael Al-Mahmeed, Chair of the Scientific Committee Al Mansouri.
Dr. Alali said: “CVD is the leading cause of death in women worldwide. However, when comparing men and women with cardiovascular disease, strokes in women are often misdiagnosed or mistreated because their symptoms do not match what doctors recognize as known heart disease , and due to insufficient awareness among women and society about female-specific symptoms.”
congenital heart defect
“Congenital heart defects are usually diagnosed at birth, and with advances in surgical treatment, there are more and more categories of adults with congenital heart defects,” said Dr Al-Mansoori.
Dr Shehab said: “Over the past decade, we have made tremendous progress in spreading awareness of cardiovascular diseases as they are the leading cause of death in women. There has also been growing awareness of the recognition, diagnosis and treatment of cardiovascular diseases High. We are now keen to focus on identifying age groups and risk for cardiovascular disease in women and working on prevention and transmission.”
Dr. Al-Mahmeed said: “More research is needed to identify the factors that contribute to the gender differences that influence and constitute traditional risk factors, understand them and work towards improving the treatment of cardiovascular disease.”
Al-Mahmeed added: “It should also communicate with health sector officials and committees responsible for clinical care to design specific interventions based on the gender of the patient.” — trade arab news agency
[ad_2]
Source link